Evaluating possible treatment effect heterogeneity in a randomized trial of milrinone versus dobutamine in cardiogenic shock
Year: 2026
Type: article
Source: Critical Care
Authors: Lucas L. Marinho, Gabriele Lileikyte, Philippe Boileau, Ying Lu, Matthew Churpek, Alexandra Spicer, Michael Harhay, Zhe Chen, Adriana Luk, Fernando G. Zampieri, Caio A. M. Tavares, Alastair Proudfoot, Cristina Pop, Patrick J. F. Deschênes, Ryan Zarychanzki, Sylvain Lother, Ludhmila Abrahão Hajjar, Jacob C. Jentzer, Sean van Diepen, Pietro di Santo, Rebecca Mathew, Patrick R. Lawler
Institutions: McGill University Health Centre, McGill University, Lund University, Skåne University Hospital, University of Wisconsin–Madison, University of Pennsylvania, University of Toronto, University of Alberta, Universidade de São Paulo, Hospital Israelita Albert Einstein, Instituto do Coração - HCFMUSP, Queen Mary University of London, Barts Health NHS Trust, University of Manitoba, Mayo Clinic, Ottawa Heart Institute
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $4,190
OpenAlex ID: W7164845343
